248 related articles for article (PubMed ID: 36456196)
1. Delta Opioid Receptor-Mediated Antidepressant-Like Effects of Diprenorphine in Mice.
Olson KM; Hillhouse TM; Burgess GE; West JL; Hallahan JE; Dripps IJ; Ladetto AG; Rice KC; Jutkiewicz EM; Traynor JR
J Pharmacol Exp Ther; 2023 Mar; 384(3):343-352. PubMed ID: 36456196
[TBL] [Abstract][Full Text] [Related]
2. Synthesis, opioid receptor binding, and bioassay of naltrindole analogues substituted in the indolic benzene moiety.
Ananthan S; Johnson CA; Carter RL; Clayton SD; Rice KC; Xu H; Davis P; Porreca F; Rothman RB
J Med Chem; 1998 Jul; 41(15):2872-81. PubMed ID: 9667975
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological Properties of
Dripps IJ; Chen R; Shafer AM; Livingston KE; Disney A; Husbands SM; Traynor JR; Rice KC; Jutkiewicz EM
J Pharmacol Exp Ther; 2020 Aug; 374(2):319-330. PubMed ID: 32467352
[TBL] [Abstract][Full Text] [Related]
4. Stereoselective interaction of ketamine with recombinant mu, kappa, and delta opioid receptors expressed in Chinese hamster ovary cells.
Hirota K; Okawa H; Appadu BL; Grandy DK; Devi LA; Lambert DG
Anesthesiology; 1999 Jan; 90(1):174-82. PubMed ID: 9915326
[TBL] [Abstract][Full Text] [Related]
5. Morphine can produce analgesia via spinal kappa opioid receptors in the absence of mu opioid receptors.
Yamada H; Shimoyama N; Sora I; Uhl GR; Fukuda Y; Moriya H; Shimoyama M
Brain Res; 2006 Apr; 1083(1):61-9. PubMed ID: 16530171
[TBL] [Abstract][Full Text] [Related]
6. Functional effects of systemically administered agonists and antagonists of mu, delta, and kappa opioid receptor subtypes on body temperature in mice.
Baker AK; Meert TF
J Pharmacol Exp Ther; 2002 Sep; 302(3):1253-64. PubMed ID: 12183687
[TBL] [Abstract][Full Text] [Related]
7. Role of signalling molecules in behaviours mediated by the δ opioid receptor agonist SNC80.
Dripps IJ; Boyer BT; Neubig RR; Rice KC; Traynor JR; Jutkiewicz EM
Br J Pharmacol; 2018 Mar; 175(6):891-901. PubMed ID: 29278419
[TBL] [Abstract][Full Text] [Related]
8. Effects of differential modulation of mu-, delta- and kappa-opioid systems on bicuculline-induced convulsions in the mouse.
Yajima Y; Narita M; Takahashi-Nakano Y; Misawa M; Nagase H; Mizoguchi H; Tseng LF; Suzuki T
Brain Res; 2000 Apr; 862(1-2):120-6. PubMed ID: 10799676
[TBL] [Abstract][Full Text] [Related]
9. Thienorphine induces antinociception without dependence through activation of κ- and δ-, and partial activation of μ- opioid receptor.
Zhou P; Li Y; Yong Z; Chen M; Zhang Y; Su R; Gong Z
Brain Res; 2020 Dec; 1748():147083. PubMed ID: 32871137
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the amino acid residues in the sixth transmembrane domains accessible in the binding-site crevices of mu, delta, and kappa opioid receptors.
Xu W; Li J; Chen C; Huang P; Weinstein H; Javitch JA; Shi L; de Riel JK; Liu-Chen LY
Biochemistry; 2001 Jul; 40(27):8018-29. PubMed ID: 11434771
[TBL] [Abstract][Full Text] [Related]
11. HS-599: a novel long acting opioid analgesic does not induce place-preference in rats.
Lattanzi R; Negri L; Giannini E; Schmidhammer H; Schutz J; Improta G
Br J Pharmacol; 2001 Sep; 134(2):441-7. PubMed ID: 11564664
[TBL] [Abstract][Full Text] [Related]
12. Synergistic antidepressant-like effects between a kappa opioid antagonist (LY2444296) and a delta opioid agonist (ADL5859) in the mouse forced swim test.
Huang P; Tunis J; Parry C; Tallarida R; Liu-Chen LY
Eur J Pharmacol; 2016 Jun; 781():53-9. PubMed ID: 27044434
[TBL] [Abstract][Full Text] [Related]
13. Differential binding properties of oripavines at cloned mu- and delta-opioid receptors.
Lee KO; Akil H; Woods JH; Traynor JR
Eur J Pharmacol; 1999 Aug; 378(3):323-30. PubMed ID: 10493109
[TBL] [Abstract][Full Text] [Related]
14. BU48: a novel buprenorphine analog that exhibits delta-opioid-mediated convulsions but not delta-opioid-mediated antinociception in mice.
Broom DC; Guo L; Coop A; Husbands SM; Lewis JW; Woods JH; Traynor JR
J Pharmacol Exp Ther; 2000 Sep; 294(3):1195-200. PubMed ID: 10945877
[TBL] [Abstract][Full Text] [Related]
15. The conserved cysteine 7.38 residue is differentially accessible in the binding-site crevices of the mu, delta, and kappa opioid receptors.
Xu W; Chen C; Huang P; Li J; de Riel JK; Javitch JA; Liu-Chen LY
Biochemistry; 2000 Nov; 39(45):13904-15. PubMed ID: 11076532
[TBL] [Abstract][Full Text] [Related]
16. Salvindolin elicits opioid system-mediated antinociceptive and antidepressant-like activities.
Keasling AW; Pandey P; Doerksen RJ; Pedrino GR; Costa EA; da Cunha LC; Zjawiony JK; Fajemiroye JO
J Psychopharmacol; 2019 Jul; 33(7):865-881. PubMed ID: 31192780
[TBL] [Abstract][Full Text] [Related]
17. Opioid interactions in rhesus monkeys: effects of delta + mu and delta + kappa agonists on schedule-controlled responding and thermal nociception.
Stevenson GW; Folk JE; Linsenmayer DC; Rice KC; Negus SS
J Pharmacol Exp Ther; 2003 Dec; 307(3):1054-64. PubMed ID: 14557380
[TBL] [Abstract][Full Text] [Related]
18. A role for the mu opioid receptor in the antidepressant effects of buprenorphine.
Robinson SA; Erickson RL; Browne CA; Lucki I
Behav Brain Res; 2017 Feb; 319():96-103. PubMed ID: 27818236
[TBL] [Abstract][Full Text] [Related]
19. Combined administration of buprenorphine and naltrexone produces antidepressant-like effects in mice.
Almatroudi A; Husbands SM; Bailey CP; Bailey SJ
J Psychopharmacol; 2015 Jul; 29(7):812-21. PubMed ID: 26045511
[TBL] [Abstract][Full Text] [Related]
20. Opioid system contribution to the antidepressant-like action of m-trifluoromethyl-diphenyl diselenide in mice: A compound devoid of tolerance and withdrawal syndrome.
Rosa SG; Pesarico AP; Tagliapietra CF; da Luz SC; Nogueira CW
J Psychopharmacol; 2017 Sep; 31(9):1250-1262. PubMed ID: 28857657
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
